SIGN UPLog In

General

Financials

Activity

Recent News
Dualyx
Dualyx
Company

Last deal

$36.08M
Local Amount - EUR 40M

Amount

Series A

Stage

15.05.2023

Date

2

all rounds

$36.08M

Total amount

Financing round

General

About Company
Dualyx develops biologic drugs for autoimmunity therapies with improved patient outcomes.

Industry

Sector :

Subsector :

Number of employees

11-50

Last funding type

Series A

IPO status

Private

Description

Founded in 2019 and based in Zwijnaarde, Belgium, Dualyx NV focuses on discovering and developing innovative biologicals to treat autoimmune and rare diseases. Their immune modulators are designed to suppress unwanted autoimmune reactions, providing lasting treatments for patients with high unmet medical needs.
Contacts

location

Ghent, Belgium

Website URL

https://www.dualyx.com/

Social url

Similar Companies
1000
Cyxone
CyxoneCyxone is a biotech company that develops drugs to improve the quality of life for people with severe autoimmune diseases.
Cyxone

Cyxone

Cyxone is a biotech company that develops drugs to improve the quality of life for people with severe autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Malmö, Sweden
ImmuneWorks
ImmuneWorksImmuneWorks develops immune tolerance treatments for serious autoimmune diseases in the lung.
ImmuneWorks

ImmuneWorks

ImmuneWorks develops immune tolerance treatments for serious autoimmune diseases in the lung.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Indianapolis, IN, USA

total rounds

3

total raised

$735K
SciRhom
SciRhomSciRhom is a biotech enterprise that develops game-changing therapies for autoimmune diseases.
SciRhom

SciRhom

SciRhom is a biotech enterprise that develops game-changing therapies for autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Martinsried, 82152 Planegg, Germany

total rounds

3

total raised

$73.27M
SuppreMol
SuppreMolSuppreMol is a biotech company that develops treatments for autoimmune diseases with the goal of curing them.
SuppreMol

SuppreMol

SuppreMol is a biotech company that develops treatments for autoimmune diseases with the goal of curing them.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Martinsried, 82152 Planegg, Germany

total rounds

5

total raised

$71M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$36.08M

Money Raised

Their latest funding was raised on 15.05.2023. Their latest investor Forbion. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
15.05.2023
Series A
9
$36.08M
Local Amount - EUR 40M
Forbion
Forbion
Fountain Healthcare Partners
Fountain Healthcare Partners
Andera Partners
Andera Partners
01.01.2020
Venture - Series Unknown
1
—
—
Forbion

Forbion

Netherlands-based venture capital firm investing in life sciences and MedTech companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Naarden, Netherlands

count Of Investments

165

count Of Exists

68
Fountain Healthcare Partners

Fountain Healthcare Partners

Fountain Healthcare Partners is an Irish-based life science venture capital fund.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Dublin, Ireland

count Of Investments

44

count Of Exists

6
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

169

count Of Exists

39
Co-Investors
Investors
9
3

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
Forbion
Forbion
Yes
Series A
Juliette Audet
Juliette Audet
Gemma Frisius Fund
Gemma Frisius Fund
No
Series A
—
PMV
PMV
No
Series A
—
Forbion

Forbion

Netherlands-based venture capital firm investing in life sciences and MedTech companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Naarden, Netherlands

count Of Investments

165

count Of Exists

68
Juliette Audet

Juliette Audet

Gemma Frisius Fund

Gemma Frisius Fund

Gemma Frisius Fund: venture capital firm in Leuven, Belgium, providing seed/start-up capital.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Leuven, Belgium

count Of Investments

30

count Of Exists

4
PMV

PMV

PMV is a private equity firm that funds promising companies' businesses, shaping the future of the Flemish economy.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Brussels, Belgium

count Of Investments

109

count Of Exists

8

Activity

Recent News
1